AbCellera Biologics Inc. (NasdaqGS: ABCL)
Health Care · Life Sciences Tools & Services · CA
$12.24
-2.08% today · +195.5% 1Y
AbCellera Biologics Inc. (NasdaqGS: ABCL) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $4.05B and employs 562 people.
Over the last twelve months the share price has gained 195.5%, trading between 2.75 and 12.15.
Tweenvest scores AbCellera Biologics Inc. across four factors: quality 37/100, value 57/100, growth 100/100. Its strongest factor is growth.
ABCL price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $4.05B
- Revenue (TTM)
- $66.17M
- P/E
- —
- EPS
- -0.55
- Dividend yield
- —
- Beta (5Y)
- 1.19
- 52-week high
- $12.15
- 52-week low
- $2.75
- Avg volume (3M)
- —
- Shares outstanding
- 324.05M
- Employees
- 562
- Next earnings
- —
About AbCellera Biologics Inc.
AbCellera Biologics Inc. specializes in pioneering an advanced platform for the discovery of antibodies. This comprehensive, AI-driven system meticulously explores and analyzes natural immune systems to identify antibodies suitable for the creation of new pharmaceutical drugs. As of December 31, 2021, the company had cultivated 156 discovery programs, ranging from completed to in-progress or under contract, in partnership with 36 entities. Notably, AbCellera maintains a crucial research collaboration and license agreement with Eli Lilly and Company. Founded in 2012, the firm is headquartered in Vancouver, Canada.
- ISIN
- CA00288U1066
- Founded
- 2012
- Listed since
- Dec 11, 2020
- Exchange
- Nasdaq Global Select
- Currency
- USD
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Thermo Fisher Scientific Inc.NYSE: TMO | $232.26B | $633.71 | +0.89% |
| Danaher CorporationNYSE: DHR | $151.82B | $215.36 | -0.28% |
| WuXi AppTec Co., Ltd.SHSE: 603259 | $71.35B | CN¥161.00 | +3.31% |
| Samsung Biologics Co.,Ltd.KOSE: A207940 | $51.75B | ₩1,551,000.00 | +0.19% |
| Lonza Group AGSWX: LONN | $51.65B | CHF587.80 | -1.01% |
| Agilent Technologies, Inc.NYSE: A | $43.71B | $155.08 | +0.20% |
| IQVIA Holdings Inc.NYSE: IQV | $42.70B | $261.51 | +0.81% |
| Waters CorporationNYSE: WAT | $40.72B | $414.17 | -0.07% |
Figures last refreshed Aug 18, 2026.